RACHEL HOFMANN: Open Payments
NPI 1568186856 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 47 payments from 15 companies in 2025. Trend: 2023 $517 · 2024 $687 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $187 |
| Axsome Therapeutics, Inc. | 6 | $101 |
| Eisai Inc. | 4 | $76 |
| Grifols USA, LLC | 3 | $52 |
| PFIZER INC. | 3 | $48 |
| Genentech USA, Inc. | 2 | $42 |
| ARGENX US, INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| HARMONY BIOSCIENCES LLC | 2 | $35 |
| Electromed, Inc. | 2 | $35 |
Products named: Sunosi, UBRELVY, Leqembi, QULIPTA, NURTEC ODT, Ocrevus Zunovo, ZEPBOUND, WAKIX.
Industry payments across NJ — which companies pay providers there.
